Identification Of Genomic Features Underlying Response Of Muscle-Invasive Bladder Cancer (Mibc) To Neoadjuvant Sorafenib, Gemcitabine, And Cisplatin (Sgc) In An Open-Label, Single-Arm, Phase 2 Study
ANNALS OF ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要